Literature DB >> 26981445

How botulinum toxin in neurogenic detrusor overactivity can reduce upper urinary tract damage?

Maximilien Baron1, Philippe Grise1, Jean-Nicolas Cornu1.   

Abstract

Intradetrusor injections of botulinum toxin are the cornerstone of medical treatment of neurogenic detrusor overactivity. The primary aim of this treatment is to ensure a low pressure regimen in the urinary bladder, but the mechanisms leading to long-term protection of the urinary tract remain poorly understood. In this paper, we highlight the potential benefits of intradetrusor injections of botulinum toxin regarding local effects on the bladder structures, urinary tract infections, stone disease, vesico ureteral reflux, hydronephrosis, renal function based on a comprehensive literature review.

Entities:  

Keywords:  Botulinum toxin; Hydronephrosis; Kidney function; Neurogenic detrusor overactivity; Urinary tract infection; Urolithiasis

Year:  2016        PMID: 26981445      PMCID: PMC4777792          DOI: 10.5527/wjn.v5.i2.195

Source DB:  PubMed          Journal:  World J Nephrol        ISSN: 2220-6124


  52 in total

1.  Saccule formation at the ureterovesical junction in smooth walled bladders.

Authors:  J A HUTCH
Journal:  J Urol       Date:  1961-10       Impact factor: 7.450

2.  Epidemiology and risk factors for urinary tract infection in patients with spinal cord injury.

Authors:  A Esclarín De Ruz; E García Leoni; R Herruzo Cabrera
Journal:  J Urol       Date:  2000-10       Impact factor: 7.450

3.  Botulinum toxin A modulates afferent fibers in neurogenic detrusor overactivity.

Authors:  A Conte; A Giannantoni; S Proietti; S Giovannozzi; G Fabbrini; A Rossi; M Porena; A Berardelli
Journal:  Eur J Neurol       Date:  2011-12-28       Impact factor: 6.089

4.  Long-term followup of renal function after spinal cord injury.

Authors:  K V Kuhlemeier; L K Lloyd; S L Stover
Journal:  J Urol       Date:  1985-09       Impact factor: 7.450

5.  Phase 3 efficacy and tolerability study of onabotulinumtoxinA for urinary incontinence from neurogenic detrusor overactivity.

Authors:  David Ginsberg; Angelo Gousse; Veronique Keppenne; Karl-Dietrich Sievert; Catherine Thompson; Wayne Lam; Mitchell F Brin; Brenda Jenkins; Cornelia Haag-Molkenteller
Journal:  J Urol       Date:  2012-04-12       Impact factor: 7.450

6.  Effect of repeated detrusor onabotulinumtoxinA injections on bladder and renal function in patients with chronic spinal cord injuries.

Authors:  Hann-Chorng Kuo; Shu-Hsin Liu
Journal:  Neurourol Urodyn       Date:  2011-06-29       Impact factor: 2.696

7.  Altered urinary bladder function in mice lacking the vanilloid receptor TRPV1.

Authors:  L A Birder; Y Nakamura; S Kiss; M L Nealen; S Barrick; A J Kanai; E Wang; G Ruiz; W C De Groat; G Apodaca; S Watkins; M J Caterina
Journal:  Nat Neurosci       Date:  2002-09       Impact factor: 24.884

8.  Effect of partial outlet obstruction on contractility: comparison between severe and mild obstruction.

Authors:  M Saito; A J Wein; R M Levin
Journal:  Neurourol Urodyn       Date:  1993       Impact factor: 2.696

9.  Trigonal injection of botulinum toxin-A does not cause vesicoureteral reflux in neurogenic patients.

Authors:  Frederico Mascarenhas; Marcello Cocuzza; Cristiano Mendes Gomes; Nilo Leão
Journal:  Neurourol Urodyn       Date:  2008       Impact factor: 2.696

Review 10.  The prevention and management of urinary tract infections among people with spinal cord injuries. National Institute on Disability and Rehabilitation Research Consensus Statement. January 27-29, 1992.

Authors: 
Journal:  J Am Paraplegia Soc       Date:  1992-07
View more
  1 in total

1.  Macroplastique and Botox are superior to Macroplastique alone in the management of neurogenic vesicoureteric reflux in spinal cord injury population with presumed healthy bladders.

Authors:  Vasileios I Sakalis; Rachel Oliver; Peter J Guy; Melissa C Davies
Journal:  J Spinal Cord Med       Date:  2018-02-07       Impact factor: 1.985

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.